Advertisement

Organisation › Details
ICR (Group)
Established in 1998, ICR partners with companies to execute strategic communications and advisory programs that achieve business goals, build awareness and credibility, and enhance long-term enterprise value. The firm’s highly differentiated service model, which pairs capital markets veterans with senior communications professionals, brings deep sector knowledge and relationships to more than 550 clients in approximately 20 industries. Today, ICR is one of the largest and most experienced independent communications and advisory firms in North America maintaining offices in New York, Norwalk, Boston, San Francisco and Beijing. ICR also advises on capital markets transactions through its ICR Capital subsidiary. *
![]() |
Start | 1998-01-01 established |
![]() |
Industry | public relations / investor relations / marcom (services) |
Industry 2 | LIFE SCIENCES | |
![]() |
Person | Ryan, Tom (ICR 202410 CEO + Co-Founder) |
![]() |
Region | New York, NY |
Country | United States (USA) | |
Street | 685 Third Avenue 2nd Floor | |
City | 10017 New York, NY | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: ICR Inc.. (1/3/19). "Press Release: ICR Acquires Westwicke Partners, North America’s Leading Healthcare-Focused IPO Advisor & Investor Relations Firm". New York, NY. | ||
Record changed: 2024-12-23 |
Advertisement

More documents for ICR (Group)
- [1] Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss....
- [2] ICR Inc.. (10/22/24). "Press Release: ICR Healthcare Launches as a Unified Global Brand in Healthcare Strategic Communications and Investor Relations". New York, NY & London....
- [3] ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY....
- [4] Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London....
- [5] Alentis Therapeutics AG. (1/9/23). "Press Release: Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1". Basel....
- [6] Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London....
- [7] OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford....
- [8] Glycotope GmbH. (3/24/22). "Press Release: Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform". Berlin....
- [9] Emergex Vaccines Holding Ltd.. (11/18/20). "Press Release: Emergex Vaccines Raises US$11 Million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases". Abingdon....
- [10] Consilium Strategic Communications Ltd.. (11/10/20). "Press Release: Consilium Strategic Communications Strengthens Global Team in the US and Europe". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top